flucytosine has been researched along with griseofulvin in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (73.17) | 18.7374 |
| 1990's | 3 (7.32) | 18.2507 |
| 2000's | 4 (9.76) | 29.6817 |
| 2010's | 4 (9.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kobayashi, GS; Medoff, G | 1 |
| Drouhet, E | 1 |
| D'Arcy, PF; Scott, EM | 1 |
| Meade, RH | 1 |
| Meinhof, W | 2 |
| Beardmore, GL | 1 |
| Hong, SS; Kim, WJ; Lee, S; Park, YK | 1 |
| Cartwright, RY | 2 |
| Hallberg, T; Jonsson, N; Mårdh, PA; Pedersen, NB | 1 |
| Björkstén, B; Quie, PG; Ray, C | 1 |
| Ajello, L; Padhye, AA; Segal, E | 1 |
| Aurich, G; Plenert, W | 1 |
| Smith, JG; Stretcher, GS | 1 |
| Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K | 1 |
| Borgers, M | 1 |
| Kerridge, D | 1 |
| Bellotti, MG; Riviera, L | 1 |
| Rankin, GO; Yang, DJ | 1 |
| Harvey, JH; Sekhon, AS; Willans, DJ | 1 |
| O'Grady, F | 1 |
| Clayton, YM | 1 |
| Roberts, DT | 1 |
| Jones, HE | 1 |
| Höffken, G; Lode, H | 1 |
| Bossa, R; Galatulas, I | 1 |
| Abbott, AB; Odds, FC | 1 |
| Yoshikawa, TT | 1 |
| Richardson, MD; Turner, A; Warnock, DW | 1 |
| Riyat, MS | 1 |
| Bickers, DR | 1 |
| Maheshwari, A; Marwaha, RK | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Borelli, C; Korting, HC; Ruge, E | 1 |
19 review(s) available for flucytosine and griseofulvin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antifungal agents: recent developments.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Fungi; Griseofulvin; Miconazole; Microtubules; Mitosis; Mycoses; Nystatin; Phenyl Ethers; Structure-Activity Relationship; Tolnaftate | 1977 |
Antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Econazole; Flucytosine; Griseofulvin; Humans; Imidazoles; Intestinal Absorption; Miconazole; Nystatin; Peptides; Polyenes | 1978 |
Antifungal agents.
Topics: Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Polyenes | 1978 |
Drug therapy reviews: clinical pharmacology and therapeutic use of antimycotic drugs.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Flucytosine; Griseofulvin; Humans; Miconazole; Nystatin | 1979 |
Cutaneous alternariosis.
Topics: Adolescent; Adult; Alternaria; Amphotericin B; Child, Preschool; Chlorquinaldol; Dermatomycoses; Female; Flucytosine; Gentian Violet; Griseofulvin; Humans; Male; Middle Aged; Mitosporic Fungi; Nystatin; Potassium Permanganate; Skin Ulcer | 1976 |
Antifungal drugs.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Blastomycosis; Candicidin; Candidiasis; Coccidioidomycosis; Colistin; Cryptococcosis; Dermatomycoses; Drug Resistance, Microbial; Emetine; Flucytosine; Griseofulvin; Histoplasmosis; Humans; Imidazoles; Minocycline; Natamycin; Nystatin; Polyenes; Tolnaftate | 1975 |
Ultrastructural correlates of antimycotic treatment.
Topics: Allylamine; Anti-Bacterial Agents; Antifungal Agents; Azoles; Flucytosine; Fungi; Griseofulvin; Humans; Polyenes | 1988 |
Mode of action of clinically important antifungal drugs.
Topics: Allylamine; Antifungal Agents; Candida albicans; Cell Membrane; Cell Nucleus; Cell Wall; Dermatomycoses; Drug Resistance, Microbial; Flucytosine; Fungi; Griseofulvin; Humans; Imidazoles; Microtubules; Mitochondria; Models, Molecular; Mycoses; Nucleic Acids; Sterols; Structure-Activity Relationship; Thymidylate Synthase | 1986 |
Nephrotoxicity of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Kidney Diseases; Mycoses | 1985 |
Pharmacokinetics of the treatment of fungal infections.
Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Aspergillus; Benzene Derivatives; Candida; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Kinetics; Mice; Microsporum; Mycoses; Natamycin; Nystatin; Trichophyton | 1972 |
Therapy of fungal infections.
Topics: Administration, Topical; Amphotericin B; Candidiasis; Coccidioides; Flucytosine; Fusarium; Griseofulvin; Histoplasma; Humans; Mycoses; Natamycin; Nystatin; Streptomyces | 1973 |
The current status of systemic antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
[Systemic antimycotic treatment].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; Ketoconazole; Miconazole; Mycoses; Piperazines; Transfer Factor | 1982 |
[Antifungal agents].
Topics: Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Mycoses; Phenyl Ethers; Polyenes; Thiocarbamates; Tolnaftate | 1981 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Systemic antifungal therapy in pediatric practice.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Child; Flucytosine; Griseofulvin; Humans; India; Mycoses | 1999 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
Current state of three-dimensional characterisation of antifungal targets and its use for molecular modelling in drug design.
Topics: Acyltransferases; Allylamine; Antifungal Agents; Aspartic Acid Endopeptidases; Azoles; Computer Simulation; Drug Design; Enzyme Inhibitors; Flucytosine; Fungal Proteins; Fungi; Glucosyltransferases; Griseofulvin; Models, Molecular; Morpholines; Polyenes | 2005 |
22 other study(ies) available for flucytosine and griseofulvin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Present state of antimycotic therapy (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Flucytosine; Griseofulvin; Humans; Imidazoles; Miconazole; Polyenes; Tinea; Tolnaftate | 1979 |
Recalcitrant sporotrichosis: a report of a patient treated with various therapies including oral miconazole and 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cautery; Cryosurgery; Curettage; Cytosine; Dermatomycoses; Evaluation Studies as Topic; Flucytosine; Griseofulvin; Hand Dermatoses; Humans; Imidazoles; Male; Miconazole; Potassium Iodide; Sporotrichosis | 1979 |
The effect of antifungal agents on pancreatic and gastric secretion in rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Bile; Body Weight; Female; Flucytosine; Gastric Juice; Griseofulvin; Pancreatic Juice; Rats | 1979 |
Use of antibiotics. Antifungals.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Infusions, Parenteral; Polyenes | 1978 |
Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.
Topics: Amphotericin B; Cells, Cultured; Chemotaxis; Flucytosine; Griseofulvin; Humans; Luminescent Measurements; Miconazole; Neutrophils; Nystatin; Phagocytosis; Zymosan | 1976 |
Susceptibility of Prototheca species to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Eukaryota; Flucytosine; Griseofulvin; Miconazole; Nystatin | 1976 |
[Therapy of generalized juvenile mycoses].
Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Drug Resistance; Flucytosine; Griseofulvin; Humans; Immunologic Deficiency Syndromes; Miconazole; Mycoses; Nystatin | 1976 |
Diagnosis and treatment of cutaneous fungus diseases.
Topics: Actinomycosis; Amphotericin B; Blastomycosis; Candida albicans; Candidiasis, Cutaneous; Chromoblastomycosis; Coccidioidomycosis; Cryptococcosis; Dermatomycoses; Flucytosine; Griseofulvin; Histoplasmosis; Mucormycosis; Mycetoma; Sporotrichosis; Tinea Capitis; Tinea Pedis; Tinea Versicolor | 1975 |
[Current problems and new developments in therapy of mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clotrimazole; Cryptococcosis; Dermatomycoses; Drug Resistance, Microbial; Flucytosine; Fungi; Griseofulvin; Humans; Miconazole; Mycoses | 1975 |
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride | 1992 |
Siccanin: a new antifungal antibiotic with antidermatophytic properties. In vitro studies.
Topics: Arthrodermataceae; Candida; Clotrimazole; Econazole; Epidermophyton; Flucytosine; Griseofulvin; Microbial Sensitivity Tests; Microsporum; Trichophyton; Xanthenes | 1985 |
Deep scopulariopsosis: a case report and sensitivity studies.
Topics: Adult; Amphotericin B; Ankle Joint; Antimony; Chronic Disease; Female; Flucytosine; Granulation Tissue; Griseofulvin; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Natamycin; Nystatin; Potassium Iodide; Staining and Labeling; Tartrates; Tendinopathy | 1974 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Injections, Intravenous; Ketoconazole; Miconazole; Piperazines; Tinea; Tinea Versicolor | 1982 |
Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro.
Topics: Antifungal Agents; Arthrodermataceae; Aspergillus; Dose-Response Relationship, Drug; Flucytosine; Griseofulvin; Imidazoles; Yeasts | 1984 |
Drugs for fungal infections.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Flucytosine; Griseofulvin; Humans; Miconazole; Mycoses; Nystatin; Potassium Iodide; Stilbamidines; Tolnaftate | 1980 |
High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Body Fluids; Chromatography, High Pressure Liquid; Flucytosine; Griseofulvin; Humans; Miconazole | 1982 |
Practical therapeutics chemotherapy of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Evaluation; Flucytosine; Griseofulvin; Humans; Mycoses | 1981 |